Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Citi
Daiichi Sankyo
McKinsey
Cantor Fitzgerald
AstraZeneca
Cerilliant
Harvard Business School
Baxter
UBS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072693

« Back to Dashboard

NDA 072693 describes NORTREL 1/35-21, which is a drug marketed by Barr and is included in one NDA. It is available from one supplier. Additional details are available on the NORTREL 1/35-21 profile page.

The generic ingredient in NORTREL 1/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 072693
Tradename:NORTREL 1/35-21
Applicant:Barr
Ingredient:ethinyl estradiol; norethindrone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 072693
Ingredient-typeProgesterone Congeners
Mechanism of ActionEstrogen Receptor Agonists
Suppliers and Packaging for NDA: 072693
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORTREL 1/35-21 ethinyl estradiol; norethindrone TABLET;ORAL-21 072693 ANDA Teva Pharmaceuticals USA, Inc. 0555-9009 0555-9009-42 3 POUCH in 1 CARTON (0555-9009-42) > 1 BLISTER PACK in 1 POUCH (0555-9009-80) > 21 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-21Strength0.035MG;1MG
Approval Date:Feb 28, 1992TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cipla
US Army
Healthtrust
Fish and Richardson
US Department of Justice
QuintilesIMS
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot